Richard Tuli, MD, PhD, is the director of radiation oncology at Tampa General Hospital as well as a professor and chair of radiation oncology at USF Health Morsani College of Medicine. Prior to joining TGH, he served as associate attending and director of developmental therapeutics at the NCI-designated comprehensive cancer center, Memorial Sloan Kettering Cancer Center in New York, and associate professor and clinical director of radiation oncology at Cedars-Sinai Medical Center in Los Angeles.
As a leader in advancing the field of radiation oncology, Dr. Tuli focuses on providing a comprehensive, multi-disciplinary and personalized experience for patients through a combination of cutting-edge technology, novel treatments and developing a connection between the patient and provider.
His current research is directed toward integrating novel molecular and targeted therapies, such as PARP inhibitors and immune therapies, with state-of-the-art radiation technologies for the treatment of pancreatic and other gastrointestinal cancers. He has served as principal investigator of many clinical trials in pancreatic cancer, served on numerous national scientific boards and leadership committees pertaining to gastrointestinal cancers, and has authored more than 100 articles, editorials and book chapters in journals such as JAMA Oncology, Clinical Cancer Research, Nature Scientific Reports, Journal of Gastrointestinal Oncology, and others. He continues to teach and mentor students, residents and fellows, many of whom have gone on to work at prominent research institutions.
“As part of a dedicated and focused team of experts at the Tampa General Hospital Center, I have the privilege of treating my patients with not only the best standard of care treatments available, but also the most cutting-edge research treatments available. I come to work every day knowing I’m bringing the best our team has to offer to fight these devastating diseases.”